Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)

PHASE3CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

September 30, 2012

Conditions
Vaccination With MenbVac
Interventions
BIOLOGICAL

MenbVac

Blood test

Trial Locations (1)

76000

UH-rouen, Rouen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Direction Générale de la Santé, France

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

Dieppe

UNKNOWN

lead

University Hospital, Rouen

OTHER